Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Perón 4190, 1414, Buenos Aires, Argentina.
Clin Rheumatol. 2019 Jul;38(7):1935-1940. doi: 10.1007/s10067-019-04463-y. Epub 2019 Feb 11.
BACKGROUND/OBJECTIVE: Our objective was to estimate incidence and prevalence rates of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) using data from a university hospital-based health management organization (HIMCO) in Latin America.
Multiple methods for case finding were used to ensure complete ascertainment. GPA was diagnosed if fulfilling ACR 1990 criteria or a clinical diagnosis was made by an experienced rheumatologist. For MPA, a clinical diagnosis made by an experienced rheumatologist in concordance with Chapel Hill 2012 consensus. Renal limited vasculitis (RLV) ANCA-P positive was considered along with MPA. Global, age-specific, and sex-specific incidence and prevalence rates were calculated for members of the HIMCO with continuous affiliation ≥ 1 year from January 2000 to January 2015. Each person was followed up until GPA or MPA were diagnosed, voluntarily withdraw of the HIMCO, death, or study finalization. Prevalence was calculated on January 1, 2015.
Nineteen incident cases of GPA and 28 of MPA were identified from January 2000 to January 2015. During this period, a total of 349,775 HIMCO persons contributed a total of 2,073,438 person-years. GPA and MPA overall incidence rate per 1,000,000 person-years were 9 (95% CI 5-13) and 14 (95% CI 9-19), respectively. Age-specific incidence rates in both female and male patients peaked in the seventh decade of life in our population. On January 1, 2015, prevalence rates were 7.4 per 100,000 (95% CI 2.8-12) for GPA and 5.2 per 100,000 (95% CI 1.3-9) for MPA. Prevalence rates were higher in ages over 70 for both genders and both diseases.
In this first study from Latin America, incidence and prevalence rates were in ranges of previous reports from other sites of the world. In our population, GPA and MPA were more frequent in women and in older ages, and the incidence of MPA was higher than that of GPA. Key points • In Argentina, MPA incidence was higher than GPA, similar to that reported in other parts of the world. • Prevalence and incidence rates were higher in ages over 70 for both sexes and both diseases.
背景/目的:我们的目的是使用拉丁美洲一家大学医院为基础的健康管理组织(HIMCO)的数据,估算肉芽肿性多血管炎(GPA)和显微镜下多血管炎(MPA)的发病率和患病率。
采用多种病例发现方法,以确保全面确定。符合 ACR 1990 标准或由经验丰富的风湿病学家做出临床诊断,则诊断 GPA。对于 MPA,由经验丰富的风湿病学家做出临床诊断,并符合 Chapel Hill 2012 共识。将肾局限性血管炎(RLV)ANCA-P 阳性与 MPA 一并考虑。对于 2000 年 1 月至 2015 年 1 月期间,连续隶属 HIMCO 满 1 年的 HIMCO 成员,计算全球、年龄特异性和性别特异性的发病率和患病率。每位患者随访至 GPA 或 MPA 诊断、自愿退出 HIMCO、死亡或研究结束。2015 年 1 月 1 日计算患病率。
从 2000 年 1 月至 2015 年 1 月,共发现 19 例 GPA 新发病例和 28 例 MPA 病例。在此期间,共有 349775 名 HIMCO 成员共提供了 2073438 人年。每 100 万人年 GPA 和 MPA 的总发病率分别为 9(95%CI 5-13)和 14(95%CI 9-19)。在我们的人群中,男女患者的年龄特异性发病率在 70 多岁时达到高峰。2015 年 1 月 1 日,GPA 的患病率为每 10 万人 7.4(95%CI 2.8-12),MPA 的患病率为每 10 万人 5.2(95%CI 1.3-9)。男女两性和两种疾病的患病率均在 70 岁以上较高。
在这项来自拉丁美洲的首次研究中,发病率和患病率处于世界其他地区以往报告的范围内。在我们的人群中,GPA 和 MPA 在女性和老年人中更为常见,并且 MPA 的发病率高于 GPA。关键点•在阿根廷,MPA 的发病率高于 GPA,与世界其他地区的报告相似。•两性和两种疾病的患病率均在 70 岁以上较高。